Chest muscle check could cut breathing tube failures
NCT ID NCT07143695
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether measuring the thickening of a small chest muscle with ultrasound can help doctors decide the best time to remove a breathing tube from critically ill patients. Removing the tube too early or too late both carry serious risks. The trial will compare standard weaning criteria plus this muscle measurement against standard criteria alone in 200 patients. The goal is to see if adding this test reduces the number of patients who need to be re-intubated.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ultrasound measurement of parasternal intercostal muscle thickening
- What this could lead to
- If successful, this could provide a simple bedside tool to better time breathing tube removal, reducing complications and re-intubation rates in intensive care.
- What could go wrong
- This is an early-stage, single-center trial with 200 patients. The measurement technique may not be reliable in all patients, and results may not apply to other hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * critically ill patient mechanically ventilated for 24 hours or more first spontaneous breathing trial Exclusion Criteria: * patient refusal difficult ultrasound views tracheostomized patient neuromuscular disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Critically ill are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cairo University
RECRUITINGCairo, Giza Governorate, 6890, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New tool aims to reduce physical restraints in ICUs
- Study aims to Fine-Tune antibiotic dosing for ICU patients
- ICU suction procedure questioned: new study looks at lung effects
- 5,000 ICU patients to help unlock secrets of critical illness
- Breath test may predict ventilator success in ICU patients
- Can extra protein help sick kids leave the ICU sooner?